期刊文献+

11例非结核分枝杆菌耐药性分析 被引量:7

下载PDF
导出
摘要 目的探讨非结核分支杆菌对常规11种抗结核药物的耐药分布及分支杆菌菌型鉴定初筛的意义。方法通过鉴别培养基(PNB和TCH)做分支杆菌菌型初筛鉴别,并回顾分析11例非结核分支杆菌临床症状及抗结核药物的耐药情况。结果非结核分支杆菌对11种抗结核药物的耐药率很高,异烟肼(H)、利福平(R)、力克肺疾(D)、氧氟沙星(O)、丙硫乙烟胺(TH)、对氨基水杨酸钠(P)的低浓度药物实验全部耐药,对高浓度药物也出现很高的耐药率。结论对涂片抗酸染色阳性者进一步做结核分支杆菌菌型初筛鉴别及药敏试验有重要临床价值。
出处 《检验医学与临床》 CAS 2010年第24期2748-2749,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献5

二级参考文献22

  • 1戴自英.实用内科学[M].北京:人民卫生出版社,1994.885-887.
  • 2[6]Dunne M.A randomized,double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus[J].Clin Infect Dis,2000,31(5):1245-52.
  • 3[7]Cohn DL.Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection.A review of recent studies in patients with AIDS[J].Drugs,1997,54:8-15.
  • 4[9]Olalla J.Mycobacterium fortuitum complex endocarditis-case report and literature review[J].Clin Microbiol Infect 2002,8(2):125-9.
  • 5[10]Nagore E.Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen[J].Acta Derm Venereol 2001,81(4):291-3.
  • 6[12]Kleinpeter M. Treatment of mycobacterial exit-site infections in patients on continuous ambulatory peritoneal dialysis[J].Adv Pert Dial,2001,17:172-5.
  • 7[13]Aubry A.Sixty-three cases of Mycobacterium marinum infection:clinical features,treatment,and antibiotic susceptibility of causative isolates[J].Arch Intern Med,2002,162(15):1746-52
  • 8[14]Espey DK.A pilot study of treatment of Buruli ulcer with rifampin and dapsone[J].Int J Infect Dis,2002,6(1):60-5.
  • 9[15]Kanga JM. Contribution of heparin therapy in the medical treatment of Buruli ulcer apropos of 1 case[J].Bull Soc Pathol Exot,2001,94(1):32-5.
  • 10龚兰生.内科手册[M].上海:上海科学技术出版社,2000.1461.

共引文献92

同被引文献36

  • 1彭涛,温博海,蹇锐,钟敏.分支杆菌临床分离株的16S rRNA基因序列分析[J].中国人兽共患病杂志,2004,20(9):772-776. 被引量:18
  • 2接力,许苗.新疆肺科医院5年结核菌培养结果分析[J].临床肺科杂志,2005,10(5):642-642. 被引量:3
  • 3结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 4中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年)[M].北京:人民卫生出版社,2010.25-52.
  • 5WHO. Global Tuberculosis Control : epidemiology, strategy, finan cing. WHO report 2009[R]. World Health Organization,2009.
  • 6World Health Organization. Guidelinesfor surveillance of drug re- sistance in tuberculosis[R]. Geneva. WHO/CDS/TB/2003,320.
  • 7World Health Organization. Policy guidance on drug susceptibility testing (DST) of second-line anti-tuberculosis drugs[J]. Geneva.
  • 8World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008 [C]. Geneva. World Health Organization,2008.
  • 9Wright A,Zignol M, Van-Deun A, et al. Epidemiology of antitu- berculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti Tuberculosis Drug Resistance Surveillance [J]. Lancet, 2009,373 : 1861.
  • 10王宇.全国第五次结核病流行病学抽样调查资料汇编[C].军事医学科学出版社,2010:26.

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部